CATHERINE BODNAR: Open Payments
NPI 1194451419 · HOWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 45 payments from 8 companies in 2025. Trend: 2023 $718 · 2024 $1,454 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $384 |
| Otsuka America Pharmaceutical, Inc. | 7 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $150 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Alkermes, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, AUSTEDO XR, SPRAVATO, LYBALVI, Sunosi.
Industry payments across NJ — which companies pay providers there.
